Expression of concern

De novo development of circulating anti-endothelial cell antibodies rather than pre-existing antibodies is associated with post-transplant allograft rejection

Paper Information

Expression of concern Details

Nature of Retraction:

Expression of concern

Retraction Notice:
10.1016/j.kint.2019.07.011

Citations (58)

58
Total Citations
15
Post-Retraction
(25.9%)
32
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
5 Within 1 year
7 After 2+ years
1216 Days since retraction (latest)
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Feb 2013
2373 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Jan 2013
2390 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Aug 2012
2557 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Jul 2012
2588 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Jun 2012
2601 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Feb 2012
2739 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Nov 2011
2816 days before retraction
Paper citing De novo development of circulating anti-endothelia...
Unknown Authors
Unknown Journal
Published: Mar 2011
3076 days before retraction
Quick Stats
Total Citations: 58
Years Since Retraction: 6.3 years
Open Access: Yes
Last Checked: Never